EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

An Explainable Clinical Decision Support Framework Using Adaptive Marine Predators Algorithm-Optimized Improved CNN For Accurate Weighted Fuzzy Production Rule Extraction

Mrs. K. Sangeetha, Dr. R. Kanakaraj

Adolescência e Saúde · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Clinical Decision Support Systems (CDSSs) need a predictive accuracy as well as interpretability to assist clinicians in disease diagnosis and risk assessment. Traditional Convolutional Neural Networks (CNNs) manage to capture complex nonlinear relations but suffer from opacity in terms of outcomes, are sensitive to initialization of hyperparameters and cannot be utilised for explainable decision-making in healthcare. This research presents a novel explainable as well as hybrid framework to integrate an Adaptive Marine Predators Algorithm (AMPA)-optimized Improved CNN with the extraction of Weighted Fuzzy Production Rule (WFPR) to bridge predictive accuracy and interpretability. The upgraded CNN employs convolutional filters operating at different scales, as well as residual connections that allow for the passage of gradients, which address the problem of vanishing gradients. In addition, it uses attention to weight features that are clinically relevant. The Adaptive Marine Predators Algorithm is put into play in the weight and hyperparameter optimization of the CNN. The model uses adaptive Brownian and Levy motion to ensure global convergence and to avoid local optima or loss in high-dimensional search spaces. The post Adaptive Marine Predators Algorithm EM Asymmetrical Black Hole Optimization appeared first on Javatpoint. The outputs of CNNs are subjected to fuzzy membership modelling. Therefore, interpretable WFPRs are inferred, transforming underlying complex learned representations into easily understandable decision rules by clinicians. This framework was tested on various clinical datasets which showed increased classification accuracy, strong training stability as well as better rule interpretability. Overall, the CDSS architecture is transparent and scalable and can ensure reliable health care insight.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Mrs. K. Sangeetha, Dr. R. Kanakaraj
Quelle
Adolescência e Saúde
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2177-5281, 1679-9941
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Mrs. K. Sangeetha, Dr. R. Kanakaraj (2026). An Explainable Clinical Decision Support Framework Using Adaptive Marine Predators Algorithm-Optimized Improved CNN For Accurate Weighted Fuzzy Production Rule Extraction. Adolescência e Saúde. https://doi.org/10.67440/ahj.vi.2004
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1